BRPI0821300A8 - Método para introduzir um átomo de flúor em uma biomolécula, bioconjugado, e, composição ligante - Google Patents

Método para introduzir um átomo de flúor em uma biomolécula, bioconjugado, e, composição ligante

Info

Publication number
BRPI0821300A8
BRPI0821300A8 BRPI0821300A BRPI0821300A BRPI0821300A8 BR PI0821300 A8 BRPI0821300 A8 BR PI0821300A8 BR PI0821300 A BRPI0821300 A BR PI0821300A BR PI0821300 A BRPI0821300 A BR PI0821300A BR PI0821300 A8 BRPI0821300 A8 BR PI0821300A8
Authority
BR
Brazil
Prior art keywords
biomolecule
introducing
fluorine atom
linker
bioconjugate
Prior art date
Application number
BRPI0821300A
Other languages
English (en)
Inventor
Liz Padilla De Jesus Omayra
William Kovacs Ernest
Eberhard Glaser Matthias
Arstad Erik
Ahmed Syud Faisal
Original Assignee
Gen Electric
Hammersmith Imanet Ltd
Ge Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/961,108 external-priority patent/US8071718B2/en
Application filed by Gen Electric, Hammersmith Imanet Ltd, Ge Healthcare Ltd filed Critical Gen Electric
Publication of BRPI0821300A2 publication Critical patent/BRPI0821300A2/pt
Publication of BRPI0821300A8 publication Critical patent/BRPI0821300A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/008—Peptides; Proteins

Abstract

MÉTODO PARA INTRODUZIR UM ÁTOMO DE FLÚOR EM UMA BIOMOLÉCULA, BIOCONJUGADO, E, COMPOSIÇÃO LIGANTE São fornecidos aqui métodos para introdução de átomo de flúor em uma biomolécula compreendendo: (i) prover um ligante contendo um terminal reativo a tiol e um terminal reativo a azido/alquino; (ii) reagir o terminal reativo a tiol do ligante com uma biomolécula contendo pelo menos um grupo tiol ou um derivado reativo do mesmo; e (iii) subsequentemente reagir o terminal reativo a azido/alquino do ligante com uma azida ou alquino substituído por flúor respectivamente. São também fornecidas composições e método de síntese de ligantes bifuncionais e bioconjugados bem como agentes de radiodiagnóstico contendo biomoléculas rotuladas com flúor.
BRPI0821300A 2007-12-20 2008-12-12 Método para introduzir um átomo de flúor em uma biomolécula, bioconjugado, e, composição ligante BRPI0821300A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/961,108 US8071718B2 (en) 2004-12-22 2007-12-20 Selective radiolabeling of biomolecules
PCT/EP2008/067413 WO2009080561A1 (en) 2007-12-20 2008-12-12 Selective radiolabeling of biomolecules

Publications (2)

Publication Number Publication Date
BRPI0821300A2 BRPI0821300A2 (pt) 2015-06-16
BRPI0821300A8 true BRPI0821300A8 (pt) 2017-10-03

Family

ID=40510013

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0821300A BRPI0821300A8 (pt) 2007-12-20 2008-12-12 Método para introduzir um átomo de flúor em uma biomolécula, bioconjugado, e, composição ligante

Country Status (14)

Country Link
EP (2) EP2231201B1 (pt)
JP (1) JP5566905B2 (pt)
KR (1) KR101563758B1 (pt)
CN (1) CN101903047B (pt)
AU (1) AU2008340449B2 (pt)
BR (1) BRPI0821300A8 (pt)
CA (1) CA2705134C (pt)
ES (1) ES2662495T3 (pt)
HK (1) HK1151225A1 (pt)
IL (1) IL205392A (pt)
MX (1) MX2010006910A (pt)
NZ (1) NZ584900A (pt)
RU (1) RU2491958C2 (pt)
WO (1) WO2009080561A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201203793D0 (en) * 2012-03-05 2012-04-18 Ge Healthcare Ltd Imaging neural activity
US9839704B2 (en) 2013-05-02 2017-12-12 Duke University Prosthetic compounds for labeling internalizing biomolecules
GB201504755D0 (en) * 2015-03-20 2015-05-06 Isis Innovation Fluorination process
KR102230657B1 (ko) * 2018-07-17 2021-03-23 한국원자력연구원 방사성 원소의 표지방법, 방사성 표지화합물 및 이를 포함하는 방사성 원소 표지 키트
AU2022207278A1 (en) * 2021-01-18 2023-08-03 Ajinomoto Co., Inc. Compound or salt thereof, and antibody obtained therefrom

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0428012D0 (en) * 2004-12-22 2005-01-26 Hammersmith Imanet Ltd Radiolabelling methods
US8067393B2 (en) * 2005-05-26 2011-11-29 Japan Science And Technology Agency Sugar-immobilized metal nanoparticle, method for measuring sugar-protein interaction using the same and method for recovering protein from sugar-protein interactant
US20070020620A1 (en) * 2005-07-14 2007-01-25 Finn M G Compositions and methods for coupling a plurality of compounds to a scaffold
WO2007080114A2 (en) * 2006-01-11 2007-07-19 Biotech Igg Ab Macromolecule conjugate

Also Published As

Publication number Publication date
RU2491958C2 (ru) 2013-09-10
JP5566905B2 (ja) 2014-08-06
CN101903047B (zh) 2015-10-21
RU2010123475A (ru) 2012-01-27
AU2008340449B2 (en) 2014-05-22
KR101563758B1 (ko) 2015-10-27
JP2011508194A (ja) 2011-03-10
EP2231201B1 (en) 2018-02-14
HK1151225A1 (zh) 2012-01-27
CN101903047A (zh) 2010-12-01
ES2662495T3 (es) 2018-04-06
EP2231201A1 (en) 2010-09-29
NZ584900A (en) 2012-09-28
CA2705134A1 (en) 2009-07-02
EP2591808A3 (en) 2014-06-25
IL205392A0 (en) 2010-12-30
EP2591808A2 (en) 2013-05-15
MX2010006910A (es) 2010-10-25
CA2705134C (en) 2018-05-08
IL205392A (en) 2015-07-30
BRPI0821300A2 (pt) 2015-06-16
AU2008340449A1 (en) 2009-07-02
KR20100098405A (ko) 2010-09-06
WO2009080561A1 (en) 2009-07-02

Similar Documents

Publication Publication Date Title
MX2010005830A (es) Conjugado de anticuerpo monoclonal anti-b7h4 - farmaco y metodos de uso del mismo.
AR110853A2 (es) Un método para preparar el conjugado de péptido insulinotrópico, y una composición farmacéutica que comprende a dicho conjugado de péptido insulinotrópico
ECSP056149A (es) Agentes citotóxicos mejorados que comprenden nuevos maitansinoides
BRPI0821300A8 (pt) Método para introduzir um átomo de flúor em uma biomolécula, bioconjugado, e, composição ligante
IN2009KN02404A (pt)
FI3268047T3 (fi) Uusia amatoksiini-vasta-ainekonjugaatteja
NO20064866L (no) IRTA-5 antistoffer og deres anvendelse
MX2009012358A (es) Agentes de formacion de imagenes opticas.
MX2010000537A (es) Anticuerpos monoclonales contra glipicano-3.
MY150246A (en) Alpha 5 - beta 1 antibodies and their uses
CY1117036T1 (el) Ανθρωπινα αντισωματα που προσδενουν cxcr4 και χρησεις αυτων
BRPI0906104B8 (pt) derivado de ácido peptonucleico, composição farmacêutica contendo uma quantidade terapeuticamente eficaz do derivado de ácido peptonucleico, método de utilização do derivado de ácido peptonucleico e composto
EA200702577A1 (ru) Способ изготовления вакцин
SG163554A1 (en) Human monoclonal antibodies to programmed death ligand 1 (pd-l1)
NO20061772L (no) Fremgangsmate for malsoking av spesifikke cellepopulasjoner ved a benytte cellebindingsmiddelmaytansinoidkonjugater bundet via en ikke-kloyvbar linker, nevnte konjugater og fremstilling av nevnte konjugater
MX2009005189A (es) Anticuerpos humanos monoclonales para btla y metodos de uso.
MX2011009220A (es) Anticuerpos completamente humanos especificos para la molecula de adhesion celular 1.
WO2008070569A3 (en) Human antibodies that bind cd22 and uses thereof
CY1113089T1 (el) Ανθρωπινα μονοκλωνικα αντισωματα σε ειδικο προστατικο μεμβρανικο αντιγονο (psma)
MX2022003740A (es) Inmunoconjugados de aminobenzazepina unidos a amida y usos de estos.
NO20082559L (no) Humane monoklonale antistoffer mot protein tyrosin kinase 7 (PTK7) og fremgangsmater for anvendelse av anti-PTK7 antistoffer
BRPI0810332A2 (pt) "politioéter envolvido com amina/hidroxi"
WO2006076691A3 (en) Irta-2 antibodies and their uses
CY1115212T1 (el) Διαμεσολαβηση στην κυτταροτοξικοτητα των κυτταρων που παρουσιαζουν eπιφaneiakh εκφραση της cd44
DE60206272D1 (de) Chelatorkonjugate mit verbesserten eigenschaften

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: GENERAL ELECTRIC COMPANY (US) , GE HEALTHCARE LIMI

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2495 DE 30-10-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.